MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Internal Medicine

Section

Internal Medicine

506 articles

Ask AI
All specialtiesInternal MedicinenewsClinical UpdatesCardiologyOncology

Latest updates

Internal Medicine

Restrictive Thyroid Incidentaloma Guidelines Cut Workload Dramatically but Miss a Small Number of Low-Risk Cancers

Conventional imaging-detected thyroid incidentalomas rarely prove malignant. A retrospective study found restrictive guidelines can sharply reduce unnecessary workup, though a small number of low-risk cancers may be missed.

Apr 19, 2026
Diabetes & Endocrinology

Genetic Variant in CUBN Gene Identified as Key Risk Factor for Metformin-Induced Vitamin B12 Deficiency

Researchers have identified a genetic variant in the cubilin gene (CUBN, rs1801222) that significantly increases the risk of metformin-induced vitamin B12 deficiency, with carriers of the AA genotype experiencing deficiency up to twice as f

Apr 17, 2026
Infectious Diseases

Fluvoxamine Shows Promise for Treating Long COVID Fatigue: Results from Adaptive Randomized Trial

A randomized trial of 399 adults with long COVID fatigue found that fluvoxamine significantly reduced fatigue severity at 60 and 90 days compared to placebo, while metformin showed no benefit. The study represents a potential breakthrough i

Apr 3, 2026
Cardiology

Cardiologist Evaluation After Postoperative Myocardial Injury Was Linked to Better 1-Year Outcomes

Post-operative cardiologist evaluation after peri-operative myocardial injury was associated with fewer major cardiac events and lower 1-year mortality in high-risk non-cardiac surgery patients.

Apr 1, 2026
Internal Medicine

Nerandomilast in Idiopathic Pulmonary Fibrosis: Long-Term Insights from the FIBRONEER-IPF Trial

An in-depth analysis of the FIBRONEER-IPF trial’s extended follow-up data, evaluating the efficacy and safety of the PDE4B inhibitor nerandomilast in reducing clinical events and mortality in patients with idiopathic pulmonary fibrosi

Mar 31, 2026Sign in to read
Critical Care

Mind the Gap: Why Point-of-Care and Central Lab Electrolytes Are Not Interchangeable in the ICU

A prospective study highlights significant discrepancies between point-of-care and central laboratory sodium and potassium measurements in the ICU, revealing a 10.48 mmol/L limit of agreement for sodium and a widespread lack of physician aw

Mar 29, 2026
Cardiology

Deciphering the Clinician’s Dilemma: Determinants of Antihypertensive Treatment Intensification in Older Adults

This review analyzes the complex factors influencing blood pressure management in older adults, highlighting how age, frailty, and digital health data shape clinician decisions and clinical inertia.

Mar 28, 2026
Internal Medicine

Nerandomilast Shows Potential Mortality Benefit in IPF Despite Neutral Composite Secondary Endpoints: Insights from FIBRONEER-IPF Extended Follow-up

Long-term data from the FIBRONEER-IPF trial indicates that while nerandomilast did not significantly impact composite respiratory events, the 18 mg dose suggests a numerical reduction in mortality and maintains a favorable safety profile fo

Mar 28, 2026
Emergency Medicine

Every Hour Counts: Emergency Department Boarding Linked to Increased Clinical Deterioration and Mortality

A large-scale retrospective study involving over 170,000 patients demonstrates that prolonged emergency department boarding significantly increases the odds of early clinical deterioration and 28-day mortality, emphasizing the urgent need f

Mar 25, 2026
Internal Medicine

Beyond Shared Identity: How Physician-Patient Racial Concordance Modulates Inpatient Advance Care Planning

A large-scale study of 390,000 hospitalizations reveals that while racial concordance modestly increases advance care planning (ACP) discussions, physician race and systemic quality initiatives play significant, nuanced roles in end-of-life

Mar 25, 2026Sign in to read
Cardiology

Redefining Gout Management: Cardiovascular Risk Reduction via Treat-to-Target Urate-Lowering Therapy

Achieving serum urate targets <6 mg/dL (or <5 mg/dL) through Treat-to-Target (T2T) protocols significantly reduces major adverse cardiovascular events in gout patients, particularly those at high baseline risk.

Mar 25, 2026
Gastroenterology

Reduced Intestinal Epithelial GPX4 Expression Predicts Postoperative Crohn’s Disease Recurrence and Offers a Novel Therapeutic Target

A breakthrough study identifies epithelial Glutathione peroxidase 4 (GPX4) deficiency as a potent predictor of Crohn’s disease recurrence after surgery. The research links this biomarker to endoplasmic reticulum stress and highlights

Mar 22, 2026Sign in to read
Diabetes & Endocrinology

Hormones and Aging, Not Just Diet: Unmasking the Sex-Specific Drivers of Plasma Ketone Levels

A large-scale analysis of the PREVEND cohort reveals that fasting β-hydroxybutyrate levels are primarily driven by sex-specific factors: oral contraceptives and menopause in women, and aging in men, challenging the dietary-centric view of k

Mar 22, 2026
Cardiology

Beyond Statins: The Evolution and Clinical Impact of PCSK9 Inhibition in Cardiovascular Risk Management

This article explores the transformation of lipid management through PCSK9 inhibitors. From genetic discovery to landmark cardiovascular outcomes trials, we examine how monoclonal antibodies, RNA interference, and gene editing are redefinin

Mar 21, 2026
Cardiology

Redefining Heart Valve Disease: The Battle Over Atrial Functional Mitral Regurgitation Guidelines

This article explores the critical differences between JACC and ESC definitions for Atrial Functional Mitral Regurgitation (AfMR), highlighting how the JACC Consensus provides a more robust prognostic framework for managing this emerging he

Mar 21, 2026Sign in to read
Diabetes & Endocrinology

Impact of Polygenic Risk Scores on the Clinical Presentation and Glycaemic Variability of GCK-MODY

This article explores how polygenic background modifies GCK-MODY clinical phenotypes, influencing HbA1c levels and diagnostic thresholds. Findings highlight the distinct polygenic patterns in GCK-MODY compared to HNF1A-MODY, emphasizing the

Mar 20, 2026
Diabetes & Endocrinology

Optimizing the ‘When’ of Exercise: Afternoon and Evening Activity as a Precision Medicine Tool for Diabetes Risk Reduction

New evidence from the UK Biobank and NHANES suggests that the timing of moderate-to-vigorous physical activity (MVPA) significantly impacts type 2 diabetes risk. Clustering activity in the afternoon and evening provides superior metabolic p

Mar 20, 2026
Cardiology

Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial

This phase 2 trial demonstrates that memantine, an NMDA receptor antagonist, significantly reduces premature atrial contractions (PACs) and nonsustained atrial tachycardia burden, suggesting the cardiac glutamatergic system as a novel thera

Mar 20, 2026
Internal Medicine

Accelerated 3-Year MD Graduates Match or Exceed Traditional Peers in Residency Performance: Evidence from ACGME Milestone 2.0

A comprehensive retrospective cohort study finds **Implementing Study Findings** I’m now integrating the Brenner et al. (2026) data into the “Key Findings” section. I’m focusing on providing a clear presentation of t

Mar 19, 2026
Internal Medicine

Post-Pandemic Firearm Acquisition and Household Exposure: Insights from the 2024 National Firearms Survey

The 2024 National Firearms Survey reveals that 29.8 million US adults acquired firearms between 2021 and 2024. This trend introduced 11.2 million new owners, significantly increasing household exposure for millions of adults and children, r

Mar 19, 2026Sign in to read
Previous
11 / 25
1…910111213…25
Next

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.